Immediately early 2 (IE-2) and DNA polymerase SiRNA as virus-specific antiviral against novel transplacental cytomegalovirus strain ALL-03 in vitro

CONCLUSION: In conclusion, this study clearly highlighted the feasibility of RNAi as an alternative antiviral therapy that could lead to controlling the CMV infection.PMID:33640483 | DOI:10.1016/j.meegid.2021.104783

Source: Infection, Genetics and Evolution - February 28, 2021 Category: Genetics & Stem Cells Authors: Krishnan Nair Balakrishnan Ashwaq Ahmed Abdullah Jamilu Abubakar Bala Faez Firdaus Abdullah Jesse Che Azurahanim Che Abdullah Mustapha Mohamed Noordin Mohd Lila Mohd-Azmi Source Type: research